SPINK5 and Eczematoid dermatitis: SPINK5 (serine peptidase inhibitor, Kazal type 5) are associated with Netherton syndrome (OMIM#256500), a disorder involving skin and hair abnormalities and a high risk of allergies, asthma, and an inflammatory skin condition, eczema.